In the latest close session, Recursion Pharmaceuticals (RXRX) was down 5.42% at $5.23. The stock fell short of the S&P 500, ...

Tencent is rated a Strong Buy, driven by renewed growth across gaming, advertising, and fintech, powered by AI integration.